Diagnostic and Predictive Value of CD133‐Positive Circulating Tumor Cells as an Indicator of Pathological High‐Risk Factors for Stage I Non‐Small Cell Lung Cancer
This study indicated that CD133-positive CTCs were associated with pathological high-risk factors, and the detection of CD133-positive CTCs may assist treatment decision-making for patients of NSCLC.
Authors
- Yousheng Mao (ORCID: https://orcid.org/0000-0003-1120-241X)
- Huandong Huo
- Zhuoheng Lv
- Kaitai Zhang (ORCID: https://orcid.org/0000-0001-9560-9641)
- Qi Zhang (ORCID: https://orcid.org/0000-0002-7918-8952)
- Xiaoli Zhang (ORCID: https://orcid.org/0000-0001-8837-8558)
- Wen Zhang (ORCID: https://orcid.org/0000-0003-3150-2751)
- Peipei Xie
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1002/cam4.71303
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cancer Foundation of China